- Email:
HSV Preparation Service for Neural Circuitry Research
Introduction
Anterograde transsynaptic tracing via the HSV-1 H129 strain is crucial for neuroscience research. The service provides customized, high-precision HSV vectors for neural circuit mapping, enabling delivery of complex genetic payloads due to HSV-1's large genome capacity. Creative Biolabs offers professional preparation with proprietary H129-dTK amplicon technology, high-titer production, and strict quality control, ensuring reliable, low-toxicity tools to support accurate connectome research and related studies.
Discover How We Can Help - Request a Consultation
HSV Preparation Service for Neural Circuitry Research
The HSV (Herpes Simplex Virus) Preparation Service provides customized, high-purity recombinant HSV vectors specifically for neural circuitry research. It focuses on anterograde trans-synaptic tracing (mainly using the HSV-1 H129 strain), while also supporting retrograde tracing and gene delivery, serving as a key tool for analyzing neural output networks and achieving precise neuronal manipulation.
Core Application Scenarios
Neural Circuit Tracing (Core Application)
- Anterograde mono-/multi-synaptic labeling: Based on the H129 strain, it accurately tracks the output pathway from neuronal axons to downstream postsynaptic neurons, enabling the analysis of whole-brain multi-level output networks, peripheral-central input/output circuits of the sensory system, and feedback circuits between high-level and low-level brain regions.
- Retrograde tracing: Based on the HSV-1 McIntyre-B strain, it achieves retrograde labeling from axon terminals to cell bodies, used to locate the upstream origin of projection neurons.
- Cross-species compatibility: Applicable to various animal models such as mice, rats, and non-human primates (NHPs), covering the research on central-peripheral neural connections.
Gene Delivery and Neuronal Manipulation
- Large-fragment gene expression: The HSV genome has a capacity of up to 150 kb, which can carry fluorescent proteins, optogenetic/chemogenetic elements, Cre/Flp recombinases, neuroactive factors, etc., to achieve specific labeling and functional regulation of neurons.
- Conditional expression system: Combined with the Cre/Flp dual-vector system, it achieves targeting of intersectional specific neuronal populations, adapting to complex logic gate experimental designs.
Disease and Developmental Research
- Neural development: Tracking the formation and remodeling process of neural networks in embryonic/young animals.
- Disease models: Analyzing abnormal neural circuit connections in models of Alzheimer's disease, Parkinson's disease, schizophrenia, etc.
- Injury repair: Evaluating the effect of circuit reconstruction and rehabilitation therapy after nerve injury.
Advantages in Technical Support and Customization
- Full-process technical guidance: Provides professional support from vector design, injection protocol to data interpretation, adapting to the needs of complex circuit research.
- Flexible customization: Supports the development of personalized vectors such as fluorescent labeling (GFP/RFP), optogenetics (NpHR), chemogenetics (DREADD), and Cre/Flp-dependent vectors.
- Cross-tool compatibility: Can be used in combination with viral tools such as AAV and RV to achieve multi-dimensional and multi-target neural circuit analysis.
III. Comparison with Other Viral Vectors (Core Differences)
| Characteristics | HSV Vectors | AAV Vectors | RV (Rabies Virus) |
|---|---|---|---|
| Trans-synaptic Direction | Anterograde (H129) / Retrograde (McIntyre-B) | Mainly Retrograde / Local | Retrograde (Mono-synaptic) |
| Gene Capacity | Large (~150 kb) | Small (~4.7 kb) | Medium (~12 kb) |
| Expression Timeframe | Fast (3-7 days) | Slow (2-4 weeks) | Medium (1-2 weeks) |
| Toxicity | Low (Replication-defective) | Very Low | Medium-High |
| Applicable Scenarios | Anterograde Circuits, Large-Fragment Delivery | Long-Term Stable Expression, Low-Toxicity Requirements | Precise Retrograde Mono-synaptic Tracing |
Workflow
Our streamlined service is designed to move your project from initial genetic concept to validated in vivo data with professional rigor.
What We Can Offer
At Creative Biolabs, we go beyond standard catalog offerings by providing a fully customizable HSV production platform that bridges the gap between laboratory discovery and large-scale preclinical evaluation.
Customized Vector Architecture
Tailored optimization of codon usage and promoter selection to maximize transgene expression in specific microorganisms or mammalian neuronal subtypes.
Scalable Production Capacities
One-stop preparation service ranging from small-scale research batches to large-scale industrial titers, utilizing advanced bioreactor technology to ensure consistency across lots.
Stability Guaranteed
Proven protocols to ensure the stability of recombinant H129-dTK strains in cell banks and during high-volume amplification cycles.
Flexible Expression Modes
Ability to run production in batch or fed-batch modes to optimize yield and viral envelope integrity based on the complexity of the genetic payload.
Rigorous Quality Framework
Implementation of Quality-by-Design (QbD) and Hazard Analysis Critical Control Point (HACCP) principles to ensure the highest standard of viral purity.
Advanced Analytical Suite
Use of high-standard QC tools to quantify viral genomic copies, infectious units, and the absence of replication-competent herpesvirus (RCH) contaminants.
Aseptic GMP-Level Verification
Strict adherence to aseptic procedures throughout the concentration and purification process to prevent immunogenic interference in in vivo applications.
Experience the Creative Biolabs Advantage - Get a Quote Today
Customer Reviews
FAQs
Q: How does your H129-dTK system prevent polysynaptic blurring?
A: Our system utilizes a "Helper-AAV" strategy. The HSV-1 H129-dTK virus can only replicate and jump to the next neuron if that "starter" neuron also expresses Thymidine Kinase (TK) provided by a co-injected AAV. This restricts the spread to exactly one synapse.
Q: Is the HSV-1 vector safe for use in BSL-2 environments?
A: Yes, our engineered HSV-1 amplicons are replication-deficient and designed for safe use in standard Biosafety Level 2 laboratories, provided standard viral handling protocols are followed.
Q: What is the maximum transgene capacity I can request?
A: Unlike AAV, which is limited to ~4.7kb, our HSV vectors can accommodate payloads up to 100kb, making them ideal for large gene clusters or multiple reporting elements.
Q: Can I target specific cell types with your HSV vectors?
A: Yes. We can incorporate Cre-dependent switches or specific promoters (e.g., GAD67, GFAP) to ensure that viral expression only occurs in your targeted neuronal or glial populations.
Q: How do I know the virus hasn't lost its transsynaptic capabilities?
A: Every batch undergoes functional validation. We provide data confirming the viral titer and sequence integrity, and we can perform in vitro spread assays to ensure the transport kinetics match the expected H129 profile.
Creative Biolabs provides the industry's most robust platform for HSV Preparation Service for Neural Circuitry Research, combining decades of virology expertise with cutting-edge genetic engineering. Whether you are mapping complex visceral pathways or developing large-scale gene therapies, our custom HSV solutions provide the precision and capacity your project demands.
Contact Our Team for More Information and to Discuss Your Project
For Research Use Only. Not For Clinical Use.